E-4031: Selective hERG Potassium Channel Blocker for Cardiac Electrophysiology Research

Executive Summary: E-4031 is a potent antiarrhythmic agent that selectively inhibits the hERG potassium channel with an IC₅₀ of 7.7 nM, serving as a benchmark tool for cardiac electrophysiology research (APExBIO). This compound induces early afterdepolarizations (EADs) and prolongs the QT interval in vitro and in vivo, facilitating the modeling of proarrhythmic substrates (Choi et al., 2025). E-4031 is widely used in advanced 3D cardiac organoid platforms for high-content screening. Its molecular profile—C₂₁H₂₇N₃O₃S, MW 401.52—enables reproducible, reliable research while requiring careful handling due to its insolubility in water. The compound is supplied by APExBIO for research use only and not for diagnostic or medical applications.

Biological Rationale

ATP-sensitive potassium channels, including the hERG channel, regulate membrane excitability in cardiac, pancreatic, muscle, and neuronal tissues. These channels couple cellular metabolic status to electrical activity by responding to changes in ATP and ADP levels. In cardiac tissue, hERG channels contribute to the rapid delayed rectifier potassium current (I_Kr), essential for repolarization of the cardiac action potential. Dysfunction of hERG channels is associated with long QT syndrome and increased risk of arrhythmias, including torsades de pointes (TdP) (Choi et al., 2025).

Mechanism of Action of E-4031

E-4031 is a highly selective blocker of the hERG (KCNH2) potassium channel, with a measured IC₅₀ of 7.7 nM under standard in vitro conditions. By binding to the inner cavity of the channel, E-4031 inhibits I_Kr current, delaying repolarization and prolonging the cardiac action potential duration. This effect is independent of sodium or calcium channel blockade, conferring high specificity. E-4031 is structurally defined as N-(4-(1-(2-(6-methylpyridin-2-yl)ethyl)piperidine-4-carbonyl)phenyl)methanesulfonamide, with a molecular weight of 401.52 and formula C₂₁H₂₇N₃O₃S (APExBIO).

Evidence & Benchmarks

• E-4031 blocks the hERG channel in human cells with an IC₅₀ of 7.7 nM, demonstrating nanomolar potency (APExBIO).
• In 3D cardiac organoids, E-4031 induces early afterdepolarizations (EADs) and prolongs field potential duration, modeling proarrhythmic risk (Choi et al., 2025).
• E-4031 application prolongs the QT interval and activation recovery interval (ARI) in animal models, with maximal effect in mid-myocardial regions during bradycardia (APExBIO).
• Blockade of I_Kr by E-4031 effectively depolarizes maximum diastolic potential and reduces upstroke velocity in isolated cardiac myocytes (Choi et al., 2025).
• Solutions of E-4031 are stable in DMSO at ≥103 mg/mL and in ethanol at ≥9.66 mg/mL with warming and ultrasonication; insoluble in water (APExBIO).

For a detailed scenario-driven guide to E-4031 in 3D cardiac workflows, see this article, which provides practical workflow optimization; this current article updates with the latest 3D cardiac organoid benchmarks and molecular detail.

Applications, Limits & Misconceptions

E-4031 is used extensively for:

• Cardiac electrophysiology research, particularly in modeling long QT syndrome and arrhythmogenic risk.
• Induction of torsades de pointes (TdP) in vitro and in vivo for pharmacological safety screening (Choi et al., 2025).
• Benchmarking proarrhythmic substrate modeling in advanced 3D cardiac organoid systems (see here for a perspective on 3D organoid analysis; this article extends with new evidence from programmable shell MEAs).
• Screening of candidate drugs for hERG liability and QT prolongation risk.

However, E-4031 is not recommended for applications outside electrophysiology research or for diagnostic/medical use. Its selectivity profile, while high, does not exclude off-target effects at supraphysiological concentrations. For practical solutions to experimental challenges, see this guide; the present article clarifies boundaries for use in 3D organoid vs. monolayer models.

Common Pitfalls or Misconceptions

• Misconception: E-4031 blocks all potassium channels equally. Clarification: It is selective for the hERG channel (KCNH2), not for all K⁺ channels.
• Pitfall: Use of E-4031 in water-based solvents. Clarification: E-4031 is insoluble in water; use DMSO or ethanol with ultrasonication.
• Misconception: E-4031 is suitable for in vivo diagnostic or therapeutic use. Clarification: It is for research use only, not approved for clinical application.
• Pitfall: Assuming long-term storage of E-4031 solutions is stable. Clarification: Stock solutions are not recommended for extended storage; prepare fresh as needed.
• Misconception: All 3D cardiac models respond identically to E-4031. Clarification: Sensitivity varies with cell composition, maturity, and assay conditions.

Workflow Integration & Parameters

E-4031 (SKU B6077, APExBIO) is supplied as a solid, purity ≥98%. Store at -20 °C, protected from light. For solution preparation, dissolve in DMSO (≥103 mg/mL) or ethanol (≥9.66 mg/mL) with gentle warming and sonication. Solutions are not recommended for long-term storage. For in vitro experiments, typical concentrations range from 1–10 nM for hERG blockade, scaling up as required for less sensitive models. In 3D cardiac organoids, E-4031 is commonly used to benchmark arrhythmogenic risk, as validated by programmable shell MEAs (Choi et al., 2025).

Shipping is on blue ice to preserve compound integrity. E-4031 is intended for scientific research only (product details).

Conclusion & Outlook

E-4031 remains an essential tool for cardiac electrophysiology and arrhythmia research, enabling robust modeling of hERG channel inhibition, QT prolongation, and arrhythmogenic risk in both 2D and 3D systems. Advances in 3D cardiac organoid technology, validated by shell microelectrode arrays, underscore E-4031's continued relevance (Choi et al., 2025). Future research will refine its applications in high-throughput pharmacological screening and disease modeling. For product specifications and ordering, consult APExBIO's E-4031 page.